EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC 4.0

Impact of Systematic Joint Examination (Ultrasound, Functional and Physical) on Treatment Management Decisions in Patients With Haemophilia A in France: Final Data From the Prospective, Observational A‐MOVE Study

Nicolas Drillaud iD, Virginie Barbay, Jean Baptiste Valentin, Romain Jailler, Aurélien Lebreton iD, Brigitte Pan-Petesch, Sabine Marie Castet iD, Birgit Frotscher, Laurent Frenzel iD, Sandrine Jousse-Joulin, Hervé Chambost, Mikaela Alenäs und 6 weitere

Haemophilia · 2025

DOI: 10.1111/hae.70012 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Haemophilia, 2025. Verfasst von Nicolas Drillaud und 17 weiteren Autor:innen. Beteiligte Einrichtung: CRC-MHC, Haemophilia Treatment Centre, University Hospital, Nantes, France. Hauptthemen laut MEDLINE: Hemophilia A, Joints, Physical Examination. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sobi in accordance with Good Publication Practice.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Haemophilia management aims to prevent bleeding and preserve joint function. Changes in patients’ joint health may influence physicians' decisions to adjust treatment. The Haemophilia Joint Health Score (HJHS) and Haemophilia Early Arthropathy Detection with Ultrasound (HEAD‐US) score assess joint health but are not routinely used.

Aim

To evaluate whether systematic joint examination with HJHS and/or HEAD‐US had an impact on treatment management decisions in France, using final data from the A‐MOVE study.

Methods

A‐MOVE (NCT04133883) was a 12‐month prospective, multicentre study, which enrolled persons with haemophilia A (all severities, aged 6–40 years) treated prophylactically or on demand with standard/extended half‐life FVIII replacement. At baseline, 6 and 12 months, HJHS/HEAD‐US and changes in patients’ management were assessed.

Results

Eighty‐six patients from 20 sites were included in the final analysis; 68 had HJHS/HEAD‐US assessments at 12 months. Over 12 months, 24.4% ( n = 21/86) of patients experienced an impact on their haemophilia management due to HJHS/HEAD‐US scores; these decisions were impacted by HJHS in about half of the patients (52.4%, n = 11/21) and HEAD‐US in almost all patients (95.2%, n = 20/21). Both assessments contributed to a change in management decisions in about half of the patients (47.6%, n = 10/21). Twenty‐nine patients (33.7%) had haemophilia management decisions impacted by factors other than HJHS/HEAD‐US, including physical examination findings ( n = 9) and the occurrence of bleeding episodes ( n = 8).

Conclusions

Final data from the A‐MOVE study show that systematic joint assessments, through functional/physical examination (HJHS) and ultrasound (HEAD‐US), may impact treatment management decisions in persons with haemophilia A.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia AJointsPhysical ExaminationHumansFranceProspective StudiesAdolescentAdultChildMaleYoung AdultUltrasonographyFemaleJoint Diseases

Stichwörter der Autor:innen

arthropathyfactor VIIIhaemophiliajointsprophylaxisultrasound

Autor:innen und Institutionen

  • CRC-MHC, Haemophilia Treatment Centre, University Hospital, Nantes, France.
  • Haemophilia Treatment Centre, University Hospital of Rouen Normandie, Rouen, France.
  • CRC-MHC Tours, Tours, France.
  • CRC-Centre Hospitalier Métropole Savoie, Chambéry, France.
  • Centre de Ressource et de Compétence des Maladies Hémorragiques Constitutionnelles, CHU Clermont-Ferrand, Hôpital Estaing, Clermont-Ferrand, France.
  • CRC-MHC Brest - Service Hématologie, Unité Hémostase Clinique, Brest, France.

ORCID-Profile: Nicolas Drillaud, Aurélien Lebreton, Sabine Marie Castet, Laurent Frenzel, Yohann Repessé

Förderung

  • Sobi in accordance with Good Publication Practice

Zitieren

APA

Drillaud, N., Barbay, V., Valentin, J. B., Jailler, R., Lebreton, A., Pan-Petesch, B., Marie Castet, S., Frotscher, B., Frenzel, L., Jousse-Joulin, S., Chambost, H., Alenäs, M., Fusser, M., Gandossi, C., Zidi, M., Mahdout, O., Repessé, Y., & A‐MOVE study group (2025). Impact of Systematic Joint Examination (Ultrasound, Functional and Physical) on Treatment Management Decisions in Patients With Haemophilia A in France: Final Data From the Prospective, Observational A‐MOVE Study. Haemophilia. https://doi.org/10.1111/hae.70012

Vancouver

Drillaud N, Barbay V, Valentin JB, Jailler R, Lebreton A, Pan-Petesch B, et al. Impact of Systematic Joint Examination (Ultrasound, Functional and Physical) on Treatment Management Decisions in Patients With Haemophilia A in France: Final Data From the Prospective, Observational A‐MOVE Study. Haemophilia. 2025. doi:10.1111/hae.70012

BibTeX
@article{Drillaud2025,
  author = {Drillaud, Nicolas and Barbay, Virginie and Valentin, Jean Baptiste and Jailler, Romain and Lebreton, Aurélien and Pan-Petesch, Brigitte and Marie Castet, Sabine and Frotscher, Birgit and Frenzel, Laurent and Jousse-Joulin, Sandrine and Chambost, Hervé and Alenäs, Mikaela and Fusser, Markus and Gandossi, Corinne and Zidi, Meriem and Mahdout, Oussama and Repessé, Yohann and A‐MOVE study group, A‐MOVE study group},
  title = {Impact of Systematic Joint Examination (Ultrasound, Functional and Physical) on Treatment Management Decisions in Patients With Haemophilia A in France: Final Data From the Prospective, Observational A‐MOVE Study},
  journal = {Haemophilia},
  year = {2025},
  doi = {10.1111/hae.70012}
}
Kostenlos starten →